Related Experiment Videos
[The thyroid function markers and their prognostic significance patients with ischemic stroke]
R Junik1, A Piechowski, J Sowiński
1Kliniki Endokrynologii AM w Poznaniu.
Neurologia I Neurochirurgia Polska
|May 1, 1995
Summary
Thyroid hormone levels change in nonthyroidal illnesses like ischemic stroke. Elevated reverse-triiodothyronine (rT3) and triiodothyronine uptake index (T3I) may predict fatal outcomes early after stroke.
Area of Science:
- Endocrinology
- Neurology
- Clinical Biochemistry
Context:
- Thyroid hormone levels are known to fluctuate in various nonthyroidal illnesses.
- Ischemic stroke is a critical neurological event that can impact systemic physiology.
- Understanding these alterations is crucial for patient management and prognosis.
Purpose:
- To investigate the specific changes in thyroid hormone serum concentrations following ischemic stroke.
- To evaluate the potential of certain thyroid hormone metabolites as early prognostic markers for fatal outcomes in stroke patients.
Summary:
- Serum concentrations of thyroxine and triiodothyronine are significantly decreased in patients post-ischemic stroke.
- Concurrently, reverse-triiodothyronine (rT3) and triiodothyronine uptake index (T3I) show considerable increases.
- These elevated rT3 and T3I levels at the onset of insult show potential as markers for fatal prognosis.
Impact:
- Provides insights into the neuroendocrine response to ischemic stroke.
- Highlights potential biomarkers (rT3, T3I) for early risk stratification in stroke patients.
- May inform future research on therapeutic interventions targeting thyroid hormone pathways in stroke recovery.